Found 285 clinical trials
The Atlanta Center for Medical Research is currently enrolling for a clinical trial evaluating an investigational drug for Schizophrenia
The Atlanta Center for Medical Research is currently enrolling for a clinical trial evaluating an investigational drug for Schizophrenia
- 996 views
- 23 Nov, 2020
- 1 location
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics.
This multicenter study will assess the effects of 24 weeks of basmisanil treatment on cognition and functioning of stable schizophrenia participants treated with antipsychotics.
- 45 views
- 22 Dec, 2020
- 1 location
Alzheimer’s Disease Research Center (ADRC) Longitudinal Study
This study is looking for people with mild cognitive impairment, young-onset Alzheimer’s, frontotemporal dementia, or Lewy body dementia. The study is also looking for cognitively-normal people over the age of 65, as a comparison. The study will follow the progression of various dementias to help with early detection, accurate diagnosis, …
- 218 views
- 25 Jan, 2022
- 1 location
Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
Confirm the efficacy of the brexpiprazole QW formulation versus placebo for acute symptoms of schizophrenia
- 1 views
- 04 Oct, 2022
- 1 location
A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy
The purpose of this study is to evaluate the efficacy of up to 3 dose levels of adjunctive JNJ-40411813 compared to placebo based on the time to baseline monthly seizure count in participants with focal onset seizures who are receiving levetiracetam or brivaracetam and up to 3 other anti-epileptic drugs …
- 21 views
- 03 Apr, 2023
- 45 locations
TMS for Symptom Reduction in Schizophrenia
investigators predict that such modulation will correct abnormal activities in patients with schizophrenia, reduce symptoms, especially auditory hallucination, and improve working memory/sustained attention
- 3 views
- 07 Apr, 2023
- 1 location
Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity (Sema)
Rates of obesity in patients with schizophrenia-spectrum disorder (SSD)s have reached epidemic proportions, with established contributing effects of antipsychotic (AP) medications. Among agents
- 0 views
- 04 Apr, 2023
- 1 location
Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer
Previous studies found that some NMDA-enhancing agents were able to improve clinical symptoms of patients with schizophrenia. Whether treatment of an NMDA-enhancing agent can benefit the
- 3 views
- 14 Nov, 2021
- 1 location
Mindfulness, Empathy and the Oxytocinergic System in Persons With Schizophrenia (OXYGEN)
Recent studies indicated positive effects of mindfulness-based interventions (MBI) for schizophrenia (SCZ), but also on oxytocin (OXT) levels in healthy persons. It was also shown that response
- 0 views
- 04 Oct, 2022
- 1 location